Discover more from PharmaFiles by Aussie17
Pfizer announces 2022 Financial highlights!
And why I think it is under-reported.
Pfizer breaks record with 100.3b Sales Achievement in 2022
Pfizer just released the 2022 financial results, and for the first time in the history of Big Pharma, they broke through $100 Billion! This is truly historic. As Professor Retsef Levi of MIT recently said,
"This is clearly the most FAILING medical product in the history of medical products... How did we end up in a situation that it's also the MOST PROFITABLE one"
When I worked in Big Pharma, during Townhall meetings, whenever Annual Results were announced, the CEO and Country GMs usually liked boasting the sales numbers by comparing them to other industries or companies.
Here are some of the boasting points I can imagine during their internal town hall meetings for this year.
Pfizer overtook Johnson and Johnson as the largest healthcare company in the world. Johnson and Johnson announced revenue of $94.9B for 2022, but note that J&J has three divisions (Pharma which is called Janssen, Medical Devices and Consumer Healthcare). Pfizer is purely Pharma. The J&J Pharma division only made $52.5b.
This is the first time a Big Pharma broke $100B. Elon Musk had to pay $44b for Twitter to buy back free speech. Pfizer made more than two times that in just one year.
It is about four times the entire Hollywood Box Office for 2022. This is an essential comparison because Hollywood is a big part of Media Propaganda, so you can see who is the actual Grand Daddy behind the scenes.
Imagine all the movie advertisements behind these blockbusters. Now you can understand why it is just peanuts for Big Pharma to buy some celebrity like Martha Stewart to be their spokeswoman.
Pfizer is now ranked number 65 in terms of Country GDP Rankings.
5. Finally, here’s the kicker. I think this number is under-reported.
Why I think the sales 100.3B is under-reported
Let me explain why. First, you need to understand three different types of sales before a drug reaches an actual patient.
When drugs exit Pfizer’s factory, they get sold to distributors in the country. This is called “Ex-factory sales.”.
The drug then gets sold by the distributors to hospitals, pharmacies and clinics. Typically the distributor marks up the price by 3-7%, so they make a profit. This is called “In-Market Sales”.
When hospitals, pharmacies and clinics sell these drugs to patients, these are called “In-Patient Sales”.
This is an overly simplistic explanation, but enough for me to illustrate what happens.
If you look at the number of COVID-19 Vaccines administered worldwide, you can see that the peak happened in 2021 and tapered off a lot in 2022 because people started realizing the vaccine is harmful. But why is this opposite of Pfizer’s 2022 record sales?
The reason is that, in Pfizer’s book, they record Ex-factory Sales instead of In-Patient Sales. So whenever governments worldwide purchase a drug from Big Pharma, they have already booked the sales. They don’t care if the drug goes to the patients or not.
This is why sometimes, you get some news about some countries destroying millions of unused drugs, like the one below. It reeks of corruption between Big Pharma and governments.
This is also a reason why the contracts between Pfizer and Governments are made in secret. Within the contracts, there is some language that says, “No refunds!”.
When Pfizer gave out the Revenue Guidance in February 2022, they expected sales to be between $98b - $102b.
They achieved sales of 100.3b, exactly within the range of Sales Guidance given in February 2022.
How do they do this? Did they have a crystal ball to make such an exact forecast? Of course not. In Pharma, we consistently achieve sales targets globally.
When you are slightly under the sales target, you simply call up your distributor or local governments to stock up on the drugs. For example, the average stock level at distributors is 60 days. But if we are 8% below the sales target, we can ask them to increase stock levels to 90 days, so we get an additional sales month before the year closes. That will ensure 100% sales achievement and a nice target bonus!
However, sometimes, sales are overachieved. For example, if they promised a sales target of $100b (like Pfizer did), and if it looks like they are going beyond $100b, they will ask the distributor / local government to push the sales to the following year (i.e. stop buying this year and buy them in January)
This will ensure they achieve both years (current and next year's) sales targets! Anyway, these are just some reasons why Big Pharma bonuses never fail year after year. Even during the 2008 Global Financial Crisis!
I believe they went way above $100.3b and pushed some sales to 2023 to soften the BIG decrease in 2023. They gave a guidance of $67b-71b for 2023, which is approximately a 30% decrease.
I think Bourla will resign soon!
I speculate that Albert Bourla will resign soon, probably sometime this year. The reason is that Pfizer has hit peak sales for now. The sales guidance for 2023 is decreasing to around $67b-$71b. Nobody wants the mRNA vaccine anymore, and as excess death increases, Bourla will get chased on the streets if he doesn’t find an exit strategy soon.
I am pretty sure he has a golden parachute arrangement, just like Moderna’s CEO Stephane Bancel, who has a $926m golden parachute.
Furthermore, his closest industry and COVID vaccine peer, Alex Gorsky, the Executive Chairman of Johnson and Johnson, quietly resigned at the end of December 2022.
Please read my previous article on why I think we are close to a SHTF moment, as everyone is fleeing a sinking ship here.